Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:25:41 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



News for U:NGNE from 2023-05-18 to 2024-05-17 - 21 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-10 17:14U:NGNESEDAR Interim MD & ASEDAR Interim MD & A
2024-05-10 17:01U:NGNESEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-10 07:30U:NGNENews ReleaseNeurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates
2024-05-07 06:19U:NGNENews ReleaseNeurogene Presents Favorable Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome during ASGCT Annual Meeting
2024-04-26 16:14U:NGNESEDAR Annual ReportSEDAR Annual Report
2024-04-22 16:36U:NGNENews ReleaseNeurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
2024-03-28 18:28U:NGNESEDAR Annual ReportSEDAR Annual Report
2024-03-28 18:15U:NGNESEDAR MD & ASEDAR MD & A
2024-03-28 18:09U:NGNESEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-18 16:14U:NGNENews ReleaseNeurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates
2024-03-04 07:30U:NGNENews ReleaseNeurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical Trial
2024-02-29 07:30U:NGNENews ReleaseNeurogene to Participate in Upcoming Investor Conferences
2024-01-16 07:00U:NGNENews ReleaseNeurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical Officer
2024-01-05 07:00U:NGNENews ReleaseNeurogene Announces Business Update and 2024 Outlook
2023-12-19 07:00U:NGNENews ReleaseNeurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million
2023-12-14 19:00U:NLTXNews ReleaseNeoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
2023-11-14 17:42U:NLTXSEDAR Interim MD & ASEDAR Interim MD & A
2023-11-14 17:41U:NLTXSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-09-22 08:00U:NLTXNews ReleaseNeoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
2023-08-11 18:55U:NLTXSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-18 06:30U:NLTXNews ReleaseNeurogene and Neoleukin Announce Definitive Merger Agreement